Drugs / NS-9
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00094003 | Sep 2002 → ? | liver and intrahepatic bile duct neoplasm, metastatic neoplasm | NS Pharma, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NS-9 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00094003 ↗ |
| Known as | Poly I: Poly C | “NS-9 [Poly I: Poly C]” NCT00094003 ↗ |
| Route | Intravenous | “once daily, 1-hour I.V. infusions of the drug” NCT00094003 ↗ |